Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/13/18 18:37 | 12/11/18 | THOR | Health | Drug | Pharmaceutical Preparations | Thompson Peter A. | CA | DT | P.d | 15,000 | 11.00 | 0 | 1,364 | 34 | 5,316 | I | |||||||||||||||
12/13/18 18:36 | 12/11/18 | THOR | Health | Drug | Pharmaceutical Preparations | Reardon Tighe | CA | O | Acting C | P.d | 6,000 | 11.00 | 0 | 545 | 46 | 1,726 | I | ||||||||||||||
12/13/18 18:35 | 12/11/18 | THOR | Health | Drug | Pharmaceutical Preparations | Lichter Jay | CA | DT | P.d | 6,000 | 11.00 | 0 | 545 | 8 | 7,568 | I | |||||||||||||||
12/13/18 18:33 | 12/11/18 | THOR | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | P.d | 15,000 | 11.00 | 0 | 1,364 | 34 | 5,316 | I | |||||||||||||||
12/13/18 18:31 | 12/11/18 | THOR | Health | Drug | Pharmaceutical Preparations | Kolchinsky Peter | MA | DT | P.d | 50,000 | 11.00 | 0 | 4,545 | 88 | 9,725 | I | |||||||||||||||
12/13/18 18:30 | 12/11/18 | THOR | Health | Drug | Pharmaceutical Preparations | Avalon Ventures X, L.P. | CA | T | P.d | 6,000 | 11.00 | 0 | 545 | 9 | 6,431 | M | |||||||||||||||
12/13/18 18:30 | 12/11/18 | THOR | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, LLC | MA | T | P.d | 50,000 | 11.00 | 0 | 4,545 | 88 | 9,725 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |